Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, USA.
Health Aff (Millwood). 2013 Feb;32(2):303-10. doi: 10.1377/hlthaff.2012.0761.
Patient decision aids, such as instructional leaflets describing treatment options for prostate cancer, are designed to help educate patients so that they can share in decisions about their care. Developers of these decision aids strive for balance, aiming to be as neutral, unbiased, and nondirective as possible. We argue that balance should not always be a goal, and we identify three situations where it should not be. For example, men diagnosed with early-stage prostate cancer frequently are not advised by their physicians that active surveillance is a reasonable alternative to immediate surgery or radiation. It may be desirable to design decision aids that promote active surveillance as an option. We recognize that the arguments put forth in this article are controversial. But they are also justified. We challenge medical decision makers and decision aid developers to determine if and when patients should be "nudged" toward one option or another.
患者决策辅助工具,如描述前列腺癌治疗选择的指导手册,旨在帮助教育患者,以便他们能够共同参与决策。这些决策辅助工具的开发者努力追求平衡,力求保持中立、客观和非引导性。我们认为,平衡不应该总是一个目标,我们确定了三种情况下不应该追求平衡的情况。例如,被诊断为早期前列腺癌的男性通常不会被医生告知主动监测是一种替代立即手术或放疗的合理选择。设计促进主动监测作为一种选择的决策辅助工具可能是可取的。我们认识到本文提出的论点是有争议的。但它们也是合理的。我们向医疗决策者和决策辅助工具开发者提出挑战,以确定是否以及何时应该“推动”患者选择一种或另一种选择。